blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3391885

EP3391885 - THERAPEUTIC AGENT FOR BREAST CANCER [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.01.2022
Database last updated on 05.05.2025
FormerThe patent has been granted
Status updated on  12.02.2021
FormerGrant of patent is intended
Status updated on  27.10.2020
FormerRequest for examination was made
Status updated on  21.09.2018
FormerThe international publication has been made
Status updated on  23.06.2017
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024  [2024/42]
Applicant(s)For all designated states
Eisai R&D Management Co., Ltd.
4-6-10 Koishikawa
Bunkyo-ku
Tokyo 112-8088 / JP
[N/P]
Former [2018/43]For all designated states
Eisai R&D Management Co., Ltd.
4-6-10 Koishikawa Bunkyo-ku
Tokyo 112-8088 / JP
Inventor(s)01 / MIYANO, Saori
c/o Eisai Co. Ltd.
Tsukuba Research Laboratories
5-1-3 Tokodai
Tsukuba-shi Ibaraki 300-2635 / JP
02 / YAMAMOTO, Yuji
c/o Eisai Co. Ltd.
Tsukuba Research Laboratories
5-1-3 Tokodai
Tsukuba-shi Ibaraki 300-2635 / JP
03 / NAKAGAWA, Takayuki
c/o Eisai Co. Ltd.
Tsukuba Research Laboratories
5-1-3 Tokodai
Tsukuba-shi Ibaraki 300-2635 / JP
 [2020/48]
Former [2018/43]01 / MIYANO Saori
c/o Eisai Co. Ltd.
Tsukuba Research Laboratories
5-1-3 Tokodai
Tsukuba-shi Ibaraki 300-2635 / JP
02 / YAMAMOTO Yuji
c/o Eisai Co. Ltd.
Tsukuba Research Laboratories
5-1-3 Tokodai
Tsukuba-shi Ibaraki 300-2635 / JP
03 / NAKAGAWA Takayuki
c/o Eisai Co. Ltd.
Tsukuba Research Laboratories
5-1-3 Tokodai
Tsukuba-shi Ibaraki 300-2635 / JP
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2018/43]
Application number, filing date16875716.915.12.2016
[2018/43]
WO2016JP87349
Priority number, dateJP2015024630817.12.2015         Original published format: JP 2015246308
[2018/43]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017104739
Date:22.06.2017
Language:JA
[2017/25]
Type: A1 Application with search report 
No.:EP3391885
Date:24.10.2018
Language:EN
[2018/43]
Type: B1 Patent specification 
No.:EP3391885
Date:17.03.2021
Language:EN
[2021/11]
Search report(s)International search report - published on:JP22.06.2017
(Supplementary) European search report - dispatched on:EP29.07.2019
ClassificationIPC:A61K31/4545, A61P15/00, A61P35/00, A61P35/04
[2019/34]
CPC:
A61K31/4545 (EP,CN,KR,RU,US); A61P15/14 (CN); A61P35/00 (CN,KR,RU);
A61P35/04 (EP,CN,US)
Former IPC [2018/43]A61K31/4545, A61P15/00, A61P35/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/43]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:THERAPEUTISCHES MITTEL GEGEN BRUSTKREBS[2018/43]
English:THERAPEUTIC AGENT FOR BREAST CANCER[2018/43]
French:AGENT THÉRAPEUTIQUE DESTINÉ AU CANCER DU SEIN[2018/43]
Entry into regional phase18.04.2018Translation filed 
18.04.2018National basic fee paid 
18.04.2018Search fee paid 
18.04.2018Designation fee(s) paid 
18.04.2018Examination fee paid 
Examination procedure18.04.2018Examination requested  [2018/43]
18.04.2018Date on which the examining division has become responsible
29.01.2020Amendment by applicant (claims and/or description)
28.10.2020Communication of intention to grant the patent
01.02.2021Fee for grant paid
01.02.2021Fee for publishing/printing paid
01.02.2021Receipt of the translation of the claim(s)
Opposition(s)20.12.2021No opposition filed within time limit [2022/08]
Fees paidRenewal fee
19.12.2018Renewal fee patent year 03
23.12.2019Renewal fee patent year 04
24.12.2020Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU15.12.2016
AL17.03.2021
AT17.03.2021
CY17.03.2021
CZ17.03.2021
DK17.03.2021
EE17.03.2021
FI17.03.2021
HR17.03.2021
LT17.03.2021
LV17.03.2021
MC17.03.2021
MK17.03.2021
MT17.03.2021
PL17.03.2021
RO17.03.2021
RS17.03.2021
SI17.03.2021
SK17.03.2021
SM17.03.2021
TR17.03.2021
BG17.06.2021
NO17.06.2021
GR18.06.2021
IS17.07.2021
PT19.07.2021
IE15.12.2021
LU15.12.2021
[2024/42]
Former [2024/29]HU15.12.2016
AL17.03.2021
AT17.03.2021
CY17.03.2021
CZ17.03.2021
DK17.03.2021
EE17.03.2021
FI17.03.2021
HR17.03.2021
LT17.03.2021
LV17.03.2021
MC17.03.2021
MK17.03.2021
PL17.03.2021
RO17.03.2021
RS17.03.2021
SI17.03.2021
SK17.03.2021
SM17.03.2021
TR17.03.2021
BG17.06.2021
NO17.06.2021
GR18.06.2021
IS17.07.2021
PT19.07.2021
IE15.12.2021
LU15.12.2021
Former [2024/22]HU15.12.2016
AL17.03.2021
AT17.03.2021
CY17.03.2021
CZ17.03.2021
DK17.03.2021
EE17.03.2021
FI17.03.2021
HR17.03.2021
LT17.03.2021
LV17.03.2021
MC17.03.2021
MK17.03.2021
PL17.03.2021
RO17.03.2021
RS17.03.2021
SI17.03.2021
SK17.03.2021
SM17.03.2021
BG17.06.2021
NO17.06.2021
GR18.06.2021
IS17.07.2021
PT19.07.2021
IE15.12.2021
LU15.12.2021
Former [2023/33]HU15.12.2016
AL17.03.2021
AT17.03.2021
CY17.03.2021
CZ17.03.2021
DK17.03.2021
EE17.03.2021
FI17.03.2021
HR17.03.2021
LT17.03.2021
LV17.03.2021
MC17.03.2021
PL17.03.2021
RO17.03.2021
RS17.03.2021
SI17.03.2021
SK17.03.2021
SM17.03.2021
BG17.06.2021
NO17.06.2021
GR18.06.2021
IS17.07.2021
PT19.07.2021
IE15.12.2021
LU15.12.2021
Former [2023/30]AL17.03.2021
AT17.03.2021
CY17.03.2021
CZ17.03.2021
DK17.03.2021
EE17.03.2021
FI17.03.2021
HR17.03.2021
LT17.03.2021
LV17.03.2021
MC17.03.2021
PL17.03.2021
RO17.03.2021
RS17.03.2021
SI17.03.2021
SK17.03.2021
SM17.03.2021
BG17.06.2021
NO17.06.2021
GR18.06.2021
IS17.07.2021
PT19.07.2021
IE15.12.2021
LU15.12.2021
Former [2022/48]AL17.03.2021
AT17.03.2021
CZ17.03.2021
DK17.03.2021
EE17.03.2021
FI17.03.2021
HR17.03.2021
LT17.03.2021
LV17.03.2021
MC17.03.2021
PL17.03.2021
RO17.03.2021
RS17.03.2021
SI17.03.2021
SK17.03.2021
SM17.03.2021
BG17.06.2021
NO17.06.2021
GR18.06.2021
IS17.07.2021
PT19.07.2021
IE15.12.2021
LU15.12.2021
Former [2022/46]AL17.03.2021
AT17.03.2021
CZ17.03.2021
DK17.03.2021
EE17.03.2021
FI17.03.2021
HR17.03.2021
LT17.03.2021
LV17.03.2021
MC17.03.2021
PL17.03.2021
RO17.03.2021
RS17.03.2021
SI17.03.2021
SK17.03.2021
SM17.03.2021
BG17.06.2021
NO17.06.2021
GR18.06.2021
IS17.07.2021
PT19.07.2021
LU15.12.2021
Former [2022/33]AL17.03.2021
AT17.03.2021
CZ17.03.2021
DK17.03.2021
EE17.03.2021
FI17.03.2021
HR17.03.2021
LT17.03.2021
LV17.03.2021
MC17.03.2021
PL17.03.2021
RO17.03.2021
RS17.03.2021
SI17.03.2021
SK17.03.2021
SM17.03.2021
BG17.06.2021
NO17.06.2021
GR18.06.2021
IS17.07.2021
PT19.07.2021
Former [2022/23]AL17.03.2021
AT17.03.2021
CZ17.03.2021
DK17.03.2021
EE17.03.2021
FI17.03.2021
HR17.03.2021
LT17.03.2021
LV17.03.2021
PL17.03.2021
RO17.03.2021
RS17.03.2021
SI17.03.2021
SK17.03.2021
SM17.03.2021
BG17.06.2021
NO17.06.2021
GR18.06.2021
IS17.07.2021
PT19.07.2021
Former [2022/13]AL17.03.2021
AT17.03.2021
CZ17.03.2021
DK17.03.2021
EE17.03.2021
FI17.03.2021
HR17.03.2021
LT17.03.2021
LV17.03.2021
PL17.03.2021
RO17.03.2021
RS17.03.2021
SI17.03.2021
SK17.03.2021
SM17.03.2021
BG17.06.2021
NO17.06.2021
GR18.06.2021
PT19.07.2021
Former [2022/10]AL17.03.2021
AT17.03.2021
CZ17.03.2021
DK17.03.2021
EE17.03.2021
FI17.03.2021
HR17.03.2021
LT17.03.2021
LV17.03.2021
PL17.03.2021
RO17.03.2021
RS17.03.2021
SK17.03.2021
SM17.03.2021
BG17.06.2021
NO17.06.2021
GR18.06.2021
PT19.07.2021
Former [2022/08]AL17.03.2021
AT17.03.2021
CZ17.03.2021
DK17.03.2021
EE17.03.2021
FI17.03.2021
HR17.03.2021
LT17.03.2021
LV17.03.2021
PL17.03.2021
RO17.03.2021
RS17.03.2021
SK17.03.2021
SM17.03.2021
BG17.06.2021
NO17.06.2021
GR18.06.2021
IS17.07.2021
PT19.07.2021
Former [2022/07]AL17.03.2021
AT17.03.2021
CZ17.03.2021
EE17.03.2021
FI17.03.2021
HR17.03.2021
LT17.03.2021
LV17.03.2021
PL17.03.2021
RO17.03.2021
RS17.03.2021
SK17.03.2021
SM17.03.2021
BG17.06.2021
NO17.06.2021
GR18.06.2021
IS17.07.2021
PT19.07.2021
Former [2021/52]AT17.03.2021
CZ17.03.2021
EE17.03.2021
FI17.03.2021
HR17.03.2021
LT17.03.2021
LV17.03.2021
PL17.03.2021
RO17.03.2021
RS17.03.2021
SK17.03.2021
SM17.03.2021
BG17.06.2021
NO17.06.2021
GR18.06.2021
IS17.07.2021
PT19.07.2021
Former [2021/51]AT17.03.2021
CZ17.03.2021
EE17.03.2021
FI17.03.2021
HR17.03.2021
LT17.03.2021
LV17.03.2021
RO17.03.2021
RS17.03.2021
SK17.03.2021
SM17.03.2021
BG17.06.2021
NO17.06.2021
GR18.06.2021
IS17.07.2021
PT19.07.2021
Former [2021/50]AT17.03.2021
CZ17.03.2021
EE17.03.2021
FI17.03.2021
HR17.03.2021
LT17.03.2021
LV17.03.2021
RO17.03.2021
RS17.03.2021
SK17.03.2021
SM17.03.2021
BG17.06.2021
NO17.06.2021
GR18.06.2021
PT19.07.2021
Former [2021/48]AT17.03.2021
CZ17.03.2021
EE17.03.2021
FI17.03.2021
HR17.03.2021
LT17.03.2021
LV17.03.2021
RS17.03.2021
SM17.03.2021
BG17.06.2021
NO17.06.2021
GR18.06.2021
Former [2021/46]AT17.03.2021
FI17.03.2021
HR17.03.2021
LT17.03.2021
LV17.03.2021
RS17.03.2021
SM17.03.2021
BG17.06.2021
NO17.06.2021
GR18.06.2021
Former [2021/37]FI17.03.2021
HR17.03.2021
LV17.03.2021
RS17.03.2021
BG17.06.2021
NO17.06.2021
GR18.06.2021
Former [2021/36]FI17.03.2021
HR17.03.2021
BG17.06.2021
NO17.06.2021
GR18.06.2021
Former [2021/35]FI17.03.2021
HR17.03.2021
NO17.06.2021
Former [2021/33]FI17.03.2021
NO17.06.2021
Documents cited:Search[Y]US2014235614  (FUNASAKA SETSUO [JP], et al);
International search[Y]JP2014237707  (EISAI R&D MAN CO LTD);
 [PY]JP5925978B  ;
by applicantUS2014235614
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.